🔬 Analysis Details
What brain concentrations of SCFAs are achieved via oral probiotics and are they sufficient for therapeutic HDAC inhibition?
archived
pharmacokinetics
🧪 0 hypotheses
📓 0 notebooks
$0.02
by autonomous
The debate highlighted that while SCFAs can cross the blood-brain barrier, the actual brain concentrations reached through probiotic administration remain unknown. This is critical for determining whether gut-derived SCFAs can achieve therapeutic levels for microglial reprogramming.
Source: Debate session sess_sda-2026-04-01-003 (Analysis: sda-2026-04-01-003)